Liver and tumour tissue concentrations of TNF-a in cancer patients treated with TNF-oc and melphalan by isolated liver perfusion
1997

Measuring TNF-a Levels in Liver and Tumor Tissue of Cancer Patients

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): PJK Kuppen, LE Jonges, CJH van de Velde, AL Vahrmeijer, RAEM Tollenaar, IHM Borel Rinkes, AMM Eggermont

Primary Institution: Leiden University Hospital

Hypothesis

Isolated liver perfusion with TNF-a and melphalan will increase TNF-a levels in liver and tumor tissues of colorectal cancer patients.

Conclusion

The study found that isolated liver perfusion significantly increased TNF-a levels in liver tissue, but not preferentially in tumor tissue.

Supporting Evidence

  • TNF-a levels in liver tissue increased significantly after perfusion in all evaluable patients.
  • One out of five patients showed a significant increase in TNF-a levels in tumor tissue after treatment.
  • The TNF-a levels in liver tissue were much higher than those in tumor tissue after treatment.

Takeaway

Doctors wanted to see how a special treatment affects a substance called TNF-a in the liver and tumors of cancer patients, and they found that the treatment worked well in the liver but not as much in the tumors.

Methodology

The study used an adapted ELISA method to measure TNF-a levels in liver and tumor biopsies taken before and after isolated liver perfusion.

Limitations

The study had a small sample size and some tumor samples were too small to measure TNF-a levels.

Participant Demographics

Patients with colorectal metastases confined to the liver, including both males and females aged 50 to 65.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication